Blastomycosis Surveillance in 5 States, United States, 1987–2018
Open accessAbstract
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases.Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.All other clinicians completing this activity will be issued a certificate of participation.To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid;and (4) view/print certificate.For CME questions, see page 1255.
AI snapshot
Written from the paper’s full text.
TL;DR
Pooled blastomycosis surveillance from 5 US states during 1987–2018 identified 4,441 cases, with high hospitalization and death proportions and long diagnostic delays, suggesting underdetection. Wisconsin had the highest burden, while incidence declined in Arkansas and remained stable in Louisiana, Michigan, and Minnesota.
Key findings
- Among 4,441 cases (Arkansas 348, Louisiana 296, Michigan 186, Minnesota 671, Wisconsin 2,904), 65% were male and median age was 46 years (range 0–97, IQR 31–59).
- Among 2,912 patients with hospitalization data, 57% were hospitalized; median length of hospitalization was 7 days (range 1–379, IQR 4–15). Among 3,385 with mortality data, 8% died; the proportion who died increased from 9.9% to 12.4% during 2007–2017 (p=0.017), while hospitalization proportion did not change significantly (p=0.252).
- Median time from symptom onset to diagnosis was 33 days (range 1–2,996; IQR 16–75; n=777). Most common symptoms were cough (79%), fever (61%), shortness of breath (55%), and weight loss (54%).
- Arkansas incidence declined from 1.3 to 0.4 cases/100,000 during 1995–2017 (p<0.001); mean annual incidence was 0.2 in Louisiana, 0.2 in Michigan, and 0.6 in Minnesota. Wisconsin peaked at >3 cases/100,000 in 2006, 2010, and 2015, with highest county-level mean annual incidence in Menominee (42.1), Lincoln (28.4), and Vilas (26.5) counties.
Methods
- Pooled deidentified surveillance data from Arkansas (Jan 1995–May 2018), Louisiana (Jan 1987–Oct 2018), Michigan (Jan 2007–Dec 2017), Minnesota (Jan 1999–Dec 2018), and Wisconsin (Jan 1990–Dec 2017); also used the Louisiana Hospital Inpatient Discharge Database for hospitalized patients during 1999–2014.
- Included data elements collected by >3 states; event date was earliest associated date; all recorded positive blastomycosis laboratory tests were considered positive, and negative tests were not routinely available.
- Calculated state- and county-level incidence using US Census Bureau population estimates; used χ2, Fisher exact, and t-tests, Cochran-Armitage tests for trends, and negative binomial regression, with p<0.05 considered significant.
Limitations
- The paper states that pooling surveillance data based on different blastomycosis case definitions is fundamentally problematic; definitions changed over time, Arkansas had no formal case definition, Michigan had none until 2012, and Wisconsin changed its definition in September 2015.
- The paper also states that combining data from different times and changing surveillance systems produced inconsistent denominators, and that race/ethnicity were often missing or unknown; environmental exposures, immunocompromised status, body site, occupation, illness duration, and treatment were not consistently available from every state.
- Evident from the text: passive surveillance likely underdetects asymptomatic or milder cases; laboratory test data were consistently available from only Arkansas, Michigan, and Minnesota, and symptom data were available only from Michigan, Minnesota, and Wisconsin beginning in 2005.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 27 cited sources checked · 0 supported · 0 flagged
- Findingown data
The proportion of blastomycosis patients who died increased from 9.9% to 12.4% during 2007-2017 (p = 0.017).
“but the proportion of patients who died increased from 9.9% to 12.4% (p = 0.017).”
Quote in the paperNot a substantial claim - Findingown data
No clear seasonal patterns in blastomycosis cases by event month were observed.
“We did not observe clear seasonal patterns by event month.”
Quote in the paperNot a substantial claim - Findingown data
Mean annual blastomycosis incidence in several northern Wisconsin counties was >20 cases/100,000.
“Consistent with previous reports, Wisconsin had the highest number of cases and incidence of the 5 states where blastomycosis is reportable, with mean annual incidence in several northern counties >20 cases/100,000 population.”
Quote in the paperNot a substantial claim - Findingown data
Mean annual blastomycosis incidence in Minnesota was 0.6 cases/100,000.
“Mean annual incidence was 0.2 cases/100,000 population in Louisiana, 0.2 cases/100,000 population in Michigan, and 0.6 cases/100,000 population in Minnesota.”
Quote in the paperNot a substantial claim - Findingown data
Mean annual blastomycosis incidence in Michigan was 0.2 cases/100,000.
“Mean annual incidence was 0.2 cases/100,000 population in Louisiana, 0.2 cases/100,000 population in Michigan, and 0.6 cases/100,000 population in Minnesota.”
Quote in the paperNot a substantial claim
- Findingown data
Blastomycosis incidence was stable during each state's surveillance period in Louisiana, Michigan, and Minnesota.
“Incidence was stable during each state’s surveillance period in Louisiana, Michigan, and Minnesota.”
Quote in the paperNot a substantial claim - Findingown data
Positive antigen test was associated with increased risk of hospitalization among blastomycosis cases (RR 1.25; 95% CI 1.13-1.37).
“Patients with positive antigen tests (RR 1.25; 95% CI 1.13–1.37), positive culture (RR 1.28; 95% CI 1.20–1.36), and positive microscopy (RR 1.32; 95% CI 1.23–1.43) were more likely to be hospitalized than patients without positive results for those laboratory tests.”
Quote in the paperNot a substantial claim - Findingown data
In Wisconsin, blastomycosis incidence peaked at >3 cases/100,000 during 2006, 2010, and 2015.
“In Wisconsin, incidence peaked at >3 cases/100,000 population during 2006, 2010, and 2015.”
Quote in the paperNot a substantial claim - Findingown data
In Arkansas, blastomycosis incidence declined from 1.3 cases/100,000 in 1995 to 0.4 cases/100,000 in 2017 (p<0.001).
“In Arkansas, incidence declined from 1.3 cases/100,000 population in 1995 to 0.4 cases/100,000 population in 2017 (p<0.001)”
Quote in the paperNot a substantial claim - Findingown data
Outbreak-associated blastomycosis cases were less likely to have died (2% vs 9%; p=0.001) than nonoutbreak cases.
“or to have died (2% vs. 9% of nonoutbreak cases; p = 0.001).”
Quote in the paperNot a substantial claim - Findingown data
The highest mean annual county-level blastomycosis incidence in Wisconsin was in Menominee (42.1), Lincoln (28.4), and Vilas (26.5) counties.
“Mean annual county-level incidence in Wisconsin was highest in Menominee (42.1 cases/100,000 population), Lincoln (28.4 cases/100,000 population), and Vilas (26.5/100,000 population) counties”
Quote in the paperNot a substantial claim - Findingown data
Older age was associated with hospitalization among blastomycosis cases (median 46 vs 44 years; p=0.015).
“The median age among hospitalized patients was 46 years compared with 44 years for nonhospitalized patients (p = 0.015).”
Quote in the paperNot a substantial claim - Findingown data
The surveillance dataset included 4,441 blastomycosis cases reported across Arkansas, Louisiana, Michigan, Minnesota, and Wisconsin during 1987-2018.
“Data were available for 4,441 cases: 348 from Arkansas, 296 from Louisiana, 186 from Michigan, 671 from Minnesota, and 2,904 from Wisconsin.”
Quote in the paperSubstantial claim - Findingown data
Positive culture was associated with increased risk of hospitalization among blastomycosis cases (RR 1.28; 95% CI 1.20-1.36).
“Patients with positive antigen tests (RR 1.25; 95% CI 1.13–1.37), positive culture (RR 1.28; 95% CI 1.20–1.36), and positive microscopy (RR 1.32; 95% CI 1.23–1.43) were more likely to be hospitalized than patients without positive results for those laboratory tests.”
Quote in the paperNot a substantial claim - Findingown data
The median time from symptom onset to diagnosis among blastomycosis patients with available data was 33 days (IQR 16-75).
“Among 777 patients with available data, the median time from symptom onset to diagnosis was 33 days (range 1–2,996 days; IQR 16–75 days).”
Quote in the paperNot a substantial claim - Findingown data
Positive microscopy test was associated with increased risk of death among blastomycosis cases (RR 1.76; 95% CI 1.34-2.38).
“Factors significantly associated with death were older age (median 61 years vs. 44 years; p<0.001) and positive microscopy test (RR 1.76; 95% CI 1.34–2.38).”
Quote in the paperNot a substantial claim - Findingown data
Among blastomycosis cases with hospitalization data, 57% (1,662/2,912) were hospitalized.
“Among 2,912 patients with hospitalization data, 57% (1,662) were hospitalized.”
Quote in the paperNot a substantial claim - Findingown data
Outbreak-associated blastomycosis cases were more often female (41% vs 34%; p=0.0365) than nonoutbreak cases.
“Outbreak cases also more often occurred among female persons (41% vs. 34% of nonoutbreak cases; p = 0.0365)”
Quote in the paperNot a substantial claim - Findingown data
Older age was associated with death among blastomycosis cases (median 61 vs 44 years; p<0.001).
“Factors significantly associated with death were older age (median 61 years vs. 44 years; p<0.001) and positive microscopy test (RR 1.76; 95% CI 1.34–2.38).”
Quote in the paperNot a substantial claim - Findingown data
Mean annual blastomycosis incidence in Louisiana was 0.2 cases/100,000.
“Mean annual incidence was 0.2 cases/100,000 population in Louisiana, 0.2 cases/100,000 population in Michigan, and 0.6 cases/100,000 population in Minnesota.”
Quote in the paperNot a substantial claim - Findingown data
Outbreak-associated blastomycosis cases were less likely to be hospitalized (45% vs 58%; p=0.003) than nonoutbreak cases.
“In addition, persons with outbreak cases were less likely to be hospitalized (45% vs. 58% of nonoutbreak cases; p = 0.003)”
Quote in the paperNot a substantial claim - Findingown data
Female sex was associated with increased risk of hospitalization among blastomycosis cases (RR 1.13; 95% CI 1.06-1.21).
“Female patients were more likely to be hospitalized (relative risk [RR] 1.13; 95% CI 1.06–1.21) than male patients.”
Quote in the paperNot a substantial claim - Findingown data
Outbreak-associated blastomycosis cases were more often nonwhite (28% vs 19%; p=0.002) than nonoutbreak cases.
“and nonwhite persons (28% vs. 19% of nonoutbreak cases; p = 0.002).”
Quote in the paperNot a substantial claim - Findingown data
Among blastomycosis cases with mortality data, 8% (278/3,385) died.
“Among 3,385 patients with mortality data, 278 (8%) died.”
Quote in the paperNot a substantial claim - Findingown data
The proportion of hospitalized blastomycosis patients did not change significantly during 2007-2017 (p = 0.252).
“The proportion of hospitalized patients did not change significantly during 2007–2017 (p = 0.252)”
Quote in the paperNot a substantial claim - Findingown data
Non-White race was associated with increased risk of hospitalization among blastomycosis cases (RR 1.13; 95% CI 1.05-1.21).
“Persons of non-White races were more likely to be hospitalized (RR 1.13; 95% CI 1.05–1.21) than persons of White race.”
Quote in the paperNot a substantial claim - Findingown data
Outbreak-associated blastomycosis cases were younger (median age 25 vs 45 years; p=0.0092) than nonoutbreak cases.
“Outbreak- cases were more frequently among younger persons (median age 25 years) than nonoutbreak cases (median age 45 years; p = 0.0092).”
Quote in the paperNot a substantial claim - Findingown data
Positive microscopy was associated with increased risk of hospitalization among blastomycosis cases (RR 1.32; 95% CI 1.23-1.43).
“Patients with positive antigen tests (RR 1.25; 95% CI 1.13–1.37), positive culture (RR 1.28; 95% CI 1.20–1.36), and positive microscopy (RR 1.32; 95% CI 1.23–1.43) were more likely to be hospitalized than patients without positive results for those laboratory tests.”
Quote in the paperNot a substantial claim - Interpretationown data
The associations between older age and confirmatory test types with hospitalization point to severe illness.
“The associations between older age and confirmatory test types with hospitalization point to severe illness, and are unsurprising”
Quote in the paperNot a substantial claim - Interpretationreasoning
Reliance on often invasive and time-consuming tests such as culture and microscopy for diagnosis likely is a key factor in underdiagnosis of blastomycosis.
“Reliance on often invasive and time-consuming tests such as culture and microscopy for diagnosis likely is a key factor in underdiagnosis of blastomycosis because these tests might not be ordered until tests for other diseases have been negative.”
Quote in the paperSubstantial claim - Interpretationown data
The high hospitalization rate of 57% demonstrates that blastomycosis surveillance detects severe cases.
“The high hospitalization rate of 57% noted in this analysis demonstrates that blastomycosis surveillance detects severe cases, which is typical for passive disease surveillance.”
Quote in the paperNot a substantial claim - Interpretationown data
The increased risk for hospitalization among persons of nonwhite races lends further evidence to the existence of blastomycosis-related health disparities.
“The increased risk for hospitalization among persons of nonwhite races lends further evidence to the existence of blastomycosis-related health disparities, as previously suspected (15–17).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [15] Khuu, 2014, Blastomycosis mortality rates, United States, 1990-2010., Emerg Infect Dis source
Not checked in the free run.
- cites [16] Lemos, 2000, Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi., Ann Diagn Pathol source
Not checked in the free run.
- cites [17] Dworkin, 2005, The epidemiology of blastomycosis in Illinois and factors associated with death., Clin Infect Dis source
Not checked in the free run.
- Interpretationcitation
The high proportion of patients with positive confirmatory laboratory tests (culture and microscopy) likely reflects detection of more severe cases.
“The high proportion of patients with positive confirmatory laboratory tests, such as culture and microscopy, likely reflects detection of more severe cases because serologic tests for blastomycosis offer only presumptive evidence of infection (12), and serologic tests were not included in most states’ case definitions (Appendix).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Saccente, 2010, Clinical and laboratory update on blastomycosis., Clin Microbiol Rev source
Not checked in the free run.
- Premisecitation
Approximately 1,000 blastomycosis-associated hospitalizations occur nationwide.
“In contrast, ≈1,000 blastomycosis-associated hospitalizations occur nationwide (10,11)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Seitz, 2014, Incidence and trends of blastomycosis-associated hospitalizations in the United States., PLoS One source
Not checked in the free run.
- cites [11] Benedict, 2019, Estimation of direct healthcare costs of fungal diseases in the United States., Clin Infect Dis source
Not checked in the free run.
- Interpretationcitation
For most states in the analysis, relatively stable incidence and hospitalization rates over time were consistent with a previous analysis of blastomycosis-related hospitalizations during 2000-2011.
“For most states in this analysis, the relatively stable incidence and hospitalization rates over time were consistent with a previous analysis of blastomycosis-related hospitalizations during 2000–2011 (10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Seitz, 2014, Incidence and trends of blastomycosis-associated hospitalizations in the United States., PLoS One source
Not checked in the free run.
- Premisecitation
This time interval is consistent with a previous report describing a median of 23 days between examination at a healthcare facility and a median of 2.5 courses of antibacterial medications for presumed bacterial infection before pulmonary blastomycosis was correctly diagnosed.
“This time interval is consistent with a previous report describing a median of 23 days between examination at a healthcare facility and a median of 2.5 courses of antibacterial medications for presumed bacterial infection before pulmonary blastomycosis was correctly diagnosed (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Alpern, 2016, Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis., Open Forum Infect Dis source
Not checked in the free run.
- Study design and conductcitation
For certain variables, such as race and ethnicity, missing data or values of "unknown" were common.
“For certain variables, such as race and ethnicity, missing data or values of “unknown” were common and demonstrate that information can be challenging to obtain because substantial time and resources often are needed to conduct case investigations (24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] McCracken S, Signs K, Stobierski M. Evaluating blastomycosis disease reporting in Michigan’s disease surveillance system. Presented at: 2018 CSTE Annual Conference; West Palm Beach, Florida, USA; June 10–14, 2018.
Not checked in the free run.
- Premisecitation
The clinical similarities between blastomycosis and other pulmonary infections often result in diagnostic delays and unnecessary empiric antimicrobial drug treatment for suspected bacterial pneumonia.
“The clinical similarities between blastomycosis and other pulmonary infections often result in diagnostic delays and unnecessary empiric antimicrobial drug treatment for suspected bacterial pneumonia (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Alpern, 2016, Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis., Open Forum Infect Dis source
Not checked in the free run.
- Study design and conductnone given
Some states' blastomycosis case definitions changed over time.
“Furthermore, some states’ case definitions changed over time.”
Quote in the paperSubstantial claim - Premisecitation
Before CSTE approved a standardized surveillance case definition in 2019, state health departments used different case definitions.
“Before the Council of State and Territorial Epidemiologists (CSTE) approved a standardized surveillance case definition in 2019 (8), state health departments used different case definitions (Appendix).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Council of State and Territorial Epidemiologists. Standardized surveillance case definition for blastomycosis 2019 [cited 2020 Mar 12]. https://cdn.ymaws.com/www.cste.org/resource/resmgr/2019ps/final/19-ID-02_Blastomycosis_final.pdf
Not checked in the free run.
- Interpretationreasoning
The observation that blastomycosis often results in severe illness might be influenced by underdetection of asymptomatic or milder, self-resolving disease.
“Blastomycosis often results in severe illness, even in previously healthy persons (9), but this observation might be influenced by underdetection of asymptomatic or milder, self-resolving disease.”
Quote in the paperNot a substantial claim - Premisecitation
Wisconsin and Minnesota conducted extensive follow-up on cases, providing deeper insight into state-specific features of blastomycosis.
“Wisconsin and Minnesota conducted extensive follow-up on cases (19,25), providing deeper insight into state-specific features of blastomycosis.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Gibbons-Burgener SN, Dieckman JL, Davis JP. Epidemiology of sporadic blastomycosis in Wisconsin, 2011–2015. Presented at: CSTE 2017 Annual Conference; Boise, Idaho, USA; June 4–8, 2017.
Not checked in the free run.
- cites [25] Ireland, 2020, Blastomycosis in Minnesota, USA, 1999-2018., Emerg Infect Dis source
Not checked in the free run.
- Interpretationcitation
The infection's true range is broader than generally appreciated.
“Cases also occur outside these regions, indicating that the infection’s true range is broader than generally appreciated (4,5).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Benedict, 2015, Mycotic infections acquired outside areas of known endemicity, United States., Emerg Infect Dis source
Not checked in the free run.
- cites [5] McDonald, 2018, Notes from the field: blastomycosis cases occurring outside of regions with known endemicity—New York, 2007–2017., MMWR Morb Mortal Wkly Rep source
Not checked in the free run.
- Study design and conductreasoning
Data about environmental exposures, immunocompromised status, body site of infection, occupation, illness duration, and treatment were not available consistently from every state.
“Data about environmental exposures, immunocompromised status, body site of infection, occupation, illness duration, and treatment were not available consistently from every state.”
Quote in the paperSubstantial claim - Premisecitation
Blastomycosis can occur in areas outside those where it is commonly recognized.
“Blastomycosis also can occur in areas outside those where it is commonly recognized (4) and might be emerging in new areas, such as east-central New York (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Benedict, 2015, Mycotic infections acquired outside areas of known endemicity, United States., Emerg Infect Dis source
Not checked in the free run.
- Study design and conductnone given
State surveillance generally collected similar demographic, clinical, and laboratory data elements, enabling comparisons across states.
“However, state surveillance generally collected similar demographic, clinical, and laboratory data elements, enabling comparisons across states.”
Quote in the paperSubstantial claim - Premisecitation
Blastomycosis might be emerging in new areas, such as east-central New York.
“Blastomycosis also can occur in areas outside those where it is commonly recognized (4) and might be emerging in new areas, such as east-central New York (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] McDonald, 2018, Notes from the field: blastomycosis cases occurring outside of regions with known endemicity—New York, 2007–2017., MMWR Morb Mortal Wkly Rep source
Not checked in the free run.
- May combine two claims. 13
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 7
May combine two claims.
Findingown dataWisconsin had the highest number of cases and incidence of the 5 states where blastomycosis is reportable.
“Consistent with previous reports, Wisconsin had the highest number of cases and incidence of the 5 states where blastomycosis is reportable, with mean annual incidence in several northern counties >20 cases/100,000 population.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationPeaks in Wisconsin blastomycosis incidence corresponded to a known outbreak at a yard waste site in 2006, an outbreak likely associated with multiple sources in 2010, and an outbreak linked to recreational tubing on the Little Wolf River in 2015.
“Peaks in incidence in Wisconsin corresponded to a known outbreak at a yard waste site in 2006 (20), an outbreak likely associated with multiple sources in 2010 (21), and an outbreak linked to recreational tubing on the Little Wolf River in 2015 (22).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [20] Pfister, 2011, Non-rural point source blastomycosis outbreak near a yard waste collection site., Clin Med Res source
Not checked in the free run.
- cites [21] Roy, 2013, A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering., Clin Infect Dis source
Not checked in the free run.
- cites [22] Koske SE, Kocharian A, Kazmierczak JJ, Gibbons-Burgener SN, Dieckman JL, Klos RF, Investigation of a large outbreak of blastomycosis caused by Blastomyces gilchristii among recreational river tubers, Wisconsin, 2015. Presented at: CSTE 2017 Annual Conference; Boise, Idaho, USA; June 4–8, 2017.
Not checked in the free run.
May combine two claims.
Findingown dataDuring 2007-2017, surveillance detected 2,111 blastomycosis cases across the five states, a mean of 192 cases per year.
“During years for which data were available from all 5 states, 2007–2017, surveillance detected 2,111 cases, a mean of 192 cases per year.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenSpodosols also occur widely in northern Michigan, where disease incidence was not elevated, and are less common in northern Minnesota, where incidence was higher.
“However, spodosols also occur widely in northern Michigan, where disease incidence was not elevated, and are less common in northern Minnesota, where incidence was higher.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe average time of >1 month from symptom onset to diagnosis indicates delays in seeking healthcare, delays in diagnosis, or both.
“The average time of >1 month from symptom onset to diagnosis indicates delays in seeking healthcare, delays in diagnosis, or both.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMost specimen types in the analysis were from bronchoalveolar lavage and lung and other tissue, which likely required biopsy.
“Accordingly, most specimen types in our analysis were from bronchoalveolar lavage and lung and other tissue, which likely required biopsy.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe annual mean of <200 cases/year and hospitalization rate of 57% suggest that ≈110 patients are hospitalized each year from states where blastomycosis is reportable.
“We found an annual mean of <200 cases/year; a hospitalization rate of 57% suggests that ≈110 patients are hospitalized each year from states where blastomycosis is reportable.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
InterpretationreasoningBlastomycosis is underdetected, even in states where it is reportable, and limited surveillance likely underdetects cases nationally.
“The median time from symptom onset to diagnosis and the severity of illness suggest that surveillance underestimates the true number of cases.”
- Also stated in: § Discussion · plain
“Our results show that blastomycosis is underdetected, even in states where it is reportable”
- Also stated in: § Discussion · hedged
“Our findings indicate that blastomycosis likely is underdetected.”
Quote in the paperSubstantial claim- Rests on an assumption: Blastomycosis is reportable in only five US states (Arkansas, Louisiana, Michigan, Minnesota, Wisconsin), so public health surveillance is limited.
- Rests on an assumption: Physician awareness of blastomycosis is probably low in most parts of the United States.
- Rests on an assumption: Acute blastomycosis illnesses can self-resolve before diagnosis.
- Also stated in: § Discussion · plain
May combine two claims.
Interpretationown dataMost blastomycosis cases occur sporadically, as outbreaks comprised <6% of cases overall.
“However, outbreaks comprised <6% of cases overall, suggesting that most cases occur sporadically, which also is true for histoplasmosis and coccidioidomycosis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMore blastomycosis hospitalizations typically occur among men.
“More blastomycosis hospitalizations typically occur among men (10,13), although a recent study found female sex was independently associated with death in blastomycosis patients with acute respiratory distress syndrome (14).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [10] Seitz, 2014, Incidence and trends of blastomycosis-associated hospitalizations in the United States., PLoS One source
Not checked in the free run.
- cites [13] Chu, 2006, Hospitalizations for endemic mycoses: a population-based national study., Clin Infect Dis source
Not checked in the free run.
May combine two claims.
Interpretationown dataBlastomycosis remains a rarely reported but severe disease in most areas where it is under public health surveillance.
“In summary, blastomycosis remains a rarely reported but severe disease in most areas where it is under public health surveillance.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningSome states' surveillance systems underwent changes during the analysis period, resulting in inconsistent denominators in the pooled analysis.
“Some states’ surveillance systems underwent changes during the analysis period; for example, data elements were added or removed, resulting in inconsistent denominators in the pooled analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost blastomycosis cases are thought to occur in the midwestern, south-central, and southeastern states, in areas surrounding the Ohio and Mississippi River valleys, the Great Lakes, and the Saint Lawrence River.
“In the United States, most blastomycosis cases are thought to occur in the midwestern, south-central, and southeastern states, in areas surrounding the Ohio and Mississippi River valleys, the Great Lakes, and the Saint Lawrence River.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [4] Benedict, 2015, Mycotic infections acquired outside areas of known endemicity, United States., Emerg Infect Dis source
Not checked in the free run.
- cites [5] McDonald, 2018, Notes from the field: blastomycosis cases occurring outside of regions with known endemicity—New York, 2007–2017., MMWR Morb Mortal Wkly Rep source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
Study design and conductnone givenPooling surveillance data based on different blastomycosis case definitions is fundamentally problematic.
“The limitations of our study include that pooling surveillance data based on different blastomycosis case definitions is fundamentally problematic; however, few other data sources would enable analyses of thousands of cases, which is helpful for studying this uncommon disease.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningCombining data from different times in each state is an additional potential limitation.
“Combining data from different times in each state is an additional potential limitation.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenWisconsin classified all blastomycosis cases as confirmed until September 2015, when their case definition changed to include confirmed and probable case classifications.
“Wisconsin classified all cases as confirmed until September 2015, when their case definition changed to include confirmed and probable case classifications”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnother study found a decline in blastomycosis-associated deaths nationwide during 1990-2010.
“Another study found a decline in blastomycosis-associated deaths nationwide during 1990–2010 (15); the reasons for the increase in deaths we observed during 2007–2017 are unclear but could reflect improvements in case follow-up, a decline in reporting of less severe cases, or other surveillance changes over time.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Khuu, 2014, Blastomycosis mortality rates, United States, 1990-2010., Emerg Infect Dis source
Not checked in the free run.
May combine two claims.
Study design and conductnone givenArkansas did not have a formal blastomycosis case definition, and Michigan did not have one until 2012.
“Although blastomycosis was reportable in each state during the years included in this analysis, Arkansas did not have a formal case definition, and Michigan did not have one until 2012.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBlastomycosis often results in severe illness, even in previously healthy persons.
“Blastomycosis often results in severe illness, even in previously healthy persons (9), but this observation might be influenced by underdetection of asymptomatic or milder, self-resolving disease.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] McBride JA, Sterkel AK, Matkovic E, Broman AT, Gibbons-Burgener SN, Gauthier GM. Clinical manifestations and outcomes in immunocompetent and immunocompromised patients with blastomycosis. Clin Infect Dis. 2020;ciaa276. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent study found female sex was independently associated with death in blastomycosis patients with acute respiratory distress syndrome.
“More blastomycosis hospitalizations typically occur among men (10,13), although a recent study found female sex was independently associated with death in blastomycosis patients with acute respiratory distress syndrome (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Rush B, Lother S, Paunovic B, Mooney O, Kumar A. Outcomes with severe blastomycosis and respiratory failure in the United States. Clin Infect Dis. 2020;ciaa294. source
Not checked in the free run.
The paper relies on this without support.
Blastomycosis is reportable in only five US states (Arkansas, Louisiana, Michigan, Minnesota, Wisconsin), so public health surveillance is limited.
“Public health surveillance for blastomycosis in the United States is limited because it is currently reportable in only 5 US states: Arkansas, Louisiana, Michigan, Minnesota, and Wisconsin.”
The paper relies on this without support.
Physician awareness of blastomycosis is probably low in most parts of the United States.
“because physician awareness of this generally uncommon disease probably is low in most parts of the United States”
The paper relies on this without support.
Acute blastomycosis illnesses can self-resolve before diagnosis.
“Because acute illnesses can self-resolve before diagnosis”
The paper relies on this without support.
Blastomycosis is not nationally notifiable, so the Centers for Disease Control and Prevention does not routinely receive case reports from states where it is reportable.
“Blastomycosis is not nationally notifiable, so the Centers for Disease Control and Prevention does not routinely receive case reports from states where it is reportable.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a survey of 4,441 blastomycosis cases in 5 US states from 1987 to 2018, 64% occurred in white persons, 17% in unknown race, 9% in black or African American persons, and 5% in Asian, Native Hawaiian, or other Pacific Islander persons.
“In a survey reporting 4,441 blastomycosis cases in 5 US states from 1987 to 2018, 2,778 (64%) occurred in white persons, 740 (17%) in persons of unknown race, 406 (9%) in black or African American persons, and 193 (5%) in Asian, Native Hawaiian, or other Pacific Islander persons.”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [173]
Blastomycosis is endemic throughout much of the midwestern US, particularly along the Great Lakes and the Mississippi, Ohio, and Saint Lawrence River valleys.
“It is endemic throughout much of the midwestern US [171,172], particularly along the Great Lakes and the Mississippi, Ohio, and Saint Lawrence River valleys [173,174].”
From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [173]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Female-sex hospitalization confidence interval differs between text and table
MinorThe text gives the lower bound of the 95% confidence interval as 1.06, whereas Table 3 gives it as 1.05.
“Female patients were more likely to be hospitalized (relative risk [RR] 1.13; 95% CI 1.06–1.21) than male patients.”
“| Female sex | 1.13 (1.05–1.21) | <0.001 | | 1.05 (0.83–1.33) | 0.681 |”
Cites
Chapman, S. W., Dismukes, W. E., Proia, L. A., Bradsher, R. W., Pappas, P. G., Threlkeld, M. G., & Kauffman, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/588300 · Cited by 751 · see citing works
Clinical and laboratory update on blastomycosis.
Saccente, M., & Woods, G. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-09 · Cited by 450 · see citing works
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438 · cited 1× · see citing works
“In contrast, ≈1,000 blastomycosis-associated hospitalizations occur nationwide (10,11), showing that the limited surveillance likely underdetects cases nationally.”
BackgroundSelf-citationHospitalizations for Endemic Mycoses: A Population-Based National Study
Chu, J. H., Feudtner, C., Heydon, K. H., Walsh, T. J., & Zaoutis, T. E. (2006) · Clinical Infectious Diseases · doi:10.1086/500405 · Cited by 254 · see citing works
Clinical Manifestations and Treatment of Blastomycosis
McBride, J. A., Gauthier, G. M., & Klein, B. S. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.006 · Cited by 213 · see citing works
Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi.
Lemos, L. B., Guo, M., & Baliga, M. (2000) · Annals of Diagnostic Pathology · doi:10.1053/adpa.2000.20755 · Cited by 134 · see citing works
The epidemiology of blastomycosis in Illinois and factors associated with death
Dworkin, M. S., Duckro, A. N., Proia, L., Semel, J. D., & Huhn, G. (2005) · Clinical Infectious Diseases · doi:10.1086/498152 · Cited by 100 · see citing works
Ecologic Niche Modeling of Blastomyces dermatitidis in Wisconsin
Reed, K. D., Meece, J. K., Archer, J. R., & Peterson, A. T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002034 · Cited by 97 · see citing works
A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering
Roy, M., Benedict, K., Deak, E., Kirby, M. A., McNiel, J. T., Sickler, C. J., Eckardt, E., Marx, R. K., Heffernan, R. T., Meece, J. K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit366 · Cited by 90 · see citing works
Self-citationMycotic Infections Acquired outside Areas of Known Endemicity, United States
Benedict, K., Thompson, G. R., Deresinski, S., & Chiller, T. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.141950 · Cited by 89 · see citing works
Self-citationMcBride, J. A., Sterkel, A., Matkovic, E., Broman, A. T., Gibbons-Burgener, S. N., & Gauthier, G. M. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa276 · Cited by 60 · see citing works
Self-citationNon-Rural Point Source Blastomycosis Outbreak Near a Yard Waste Collection Site
Pfister, J., Archer, J. R., Hersil, S., Boers, T., Reed, K. D., Meece, J. K., Anderson, J. L., Burgess, J. W., Sullivan, T. D., Klein, B. S., et al. (2010) · Clinical Medicine & Research · doi:10.3121/cmr.2010.958 · Cited by 57 · see citing works
Incidence and trends of blastomycosis-associated hospitalizations in the United States.
Seitz, A. E., Younes, N., Steiner, C. A., & Prevots, D. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105466 · Cited by 51 · see citing works
Blastomycosis mortality rates, United States, 1990–2010
Khuu, D., Shafir, S., Bristow, B., & Sorvillo, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.131175 · Cited by 47 · see citing works
McTaggart, L. R., Brown, E. M., & Richardson, S. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159396 · Cited by 47 · see citing works
Diagnostic delay and antibiotic overuse in acute pulmonary blastomycosis.
Alpern, J. D., Bahr, N. C., Vazquez-Benitez, G., Boulware, D. R., Sellman, J. S., & Sarosi, G. A. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw078 · Cited by 42 · see citing works
McDonald, R., Dufort, E., Jackson, B. R., Tobin, E. H., Newman, A., Benedict, K., & Blog, D. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6738a8 · Cited by 40 · see citing works
Self-citationMerkhofer, R. M., O’Neill, M. B., Xiong, D., Hernandez-Santos, N., Dobson, H., Fites, J. S., Shockey, A. C., Wuethrich, M., Pepperell, C. S., & Klein, B. S. (2019) · mBio · doi:10.1128/mbio.01224-19 · Cited by 39 · see citing works
Blastomycosis in Minnesota, USA, 1999-2018.
Ireland, M., Klumb, C., Smith, K., & Scheftel, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2605.191074 · Cited by 37 · see citing works
Self-citationOutcomes With Severe Blastomycosis and Respiratory Failure in the United States
Rush, B. N. M., Lother, S., Paunovic, B. N., Mooney, O., & Kumar, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa294 · Cited by 19 · see citing works
Epidemiology of Sporadic Blastomycosis in Wisconsin, 2011-2015
Gibbons-Burgener, S. N. (2017) · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Koske SE, Kocharian A, Kazmierczak JJ, Gibbons-Burgener SN, Dieckman JL, Klos RF, Investigation of a large outbreak of blastomycosis caused by Blastomyces gilchristii among recreational river tubers, Wisconsin, 2015. Presented at: CSTE 2017 Annual Conference; Boise, Idaho, USA; June 4–8, 2017.
- McCracken S, Signs K, Stobierski M. Evaluating blastomycosis disease reporting in Michigan’s disease surveillance system. Presented at: 2018 CSTE Annual Conference; West Palm Beach, Florida, USA; June 10–14, 2018.
Cited by
Sorted by citations
Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis—United States, 2019.
Smith, D. J., Williams, S. L., Endemic Mycoses State Partners Group, Benedict, K. M., Jackson, B. R., Toda, M., Endemic Mycoses State Partners Group, Adame, G., Rothfeldt, L., Cooksey, G. S., et al. (2022) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7107a1 · Cited by 75 · see citing works
Self-citationRace and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55 · see citing works
- Authors
- Benedict, K., Gibbons-Burgener, S., Kocharian, A., Ireland, M., Rothfeldt, L., Christophe, N., Signs, K., & Jackson, B. R.
- Affiliations
- Wisconsin Department of Health Services (US)
- Corresponding author
- Benedict, Kaitlin
- ORCID
- Venue
- Emerging Infectious Diseases
- Published
- 2021-04
- Volume
- 27
- Issue
- 4
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC8007286
- OpenAlex
- W3135927290
- Semantic Scholar
- 4933d8fca005463f05629ae5c272f668e64c2e03
- Cited by
- 29
- References
- 21
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 14 · 2023: 5 · 2022: 2
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Microbiology › Actinomycetales infections and treatment
- Keywords
- blastomycosis, disease surveillance, fungal infection, Blastomyces dermatitidis, United States
- MeSH terms
- Blastomycosis, Humans, United States, Wisconsin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review